alexa Prolactinoma | Norway | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

Prolactinoma

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Prolactinoma

    Prolactinomas are the most common hormone-secreting pituitary tumors. It is a noncancerous (benign) pituitary tumor that produces a hormone called prolactin. This results in too much prolactin in the blood. These occur most commonly in people under age 40. They are about five times more common in women than in men, but are rare in children. Larger tumors are more common in men. They tend to occur at an older age. The tumor can grow to a large size before symptoms appear.

  • Prolactinoma

    Pathophysiology: Tumor formation is due to neoplastic transformation of anterior pituitary lactotrophs, resulting in excess synthesis and secretion of prolactin (PRL). Linkage to aryl hydrocarbon-interacting protein gene (AIP) mutation has been identified in some families with prolactinoma and in childhood-onset pituitary adenomas.

  • Prolactinoma

    Treatment: Prolactinomas can usually be treated successfully with medication alone. Medication lowers the prolactin level in the blood substantially, often to normal, and also usually reduces adenoma size. However, a minority of these adenomas do not respond to medication and must be treated with surgery or, less commonly, radiation therapy.

 

High Impact List of Articles

Conference Proceedings